July 2016

Facility Expansions

Exicure is a clinical stage biotechnology company developing a new class of immunomodulatory and gene silencing drugs against validated targets. Their 3-dimensional, spherical nucleic acid (SNA™) architecture unlocks the potential of nucleic acid therapeutics in multiple organs.
 
Exicure has recently expanded due to the fact that they were growing beyond their original space. They have begun clinical trial with their first compound, AST-005 gel for chronic plaque psoriasis, an inflammatory disease that results in red, scaly patches on the skin. They anticipate more compounds to enter the clinic over next 12 months. Due to this and growth of the preclinical efforts, it was best to get some additional space.
 
NuMat Technologies is a nanotechnology company that is fundamentally challenging the need to compress gases.  They design and build systems that allow gases to be stored and separated with lower energy costs, greater safety, and new form factors. The materials developed by NuMat have wide ranging applications in the energy, healthcare, defense, and technology industries. 
 
NuMat is completing a manufacturing line for its next generation gas storage technology. The product will be the world's first to commercially integrate Metal-Organic Frameworks, a new class of ultra-high performing adsorbents

 

Posted in: